Treating SLE: Benlysta® (Human Genome Sciences/ GlaxoSmithKline), was approved by the U.S. Food and Drug Administration (FDA) on March 10, 2011, for the treatment of active, autoantibody-positive systemic lupus erythematosus (SLE).
Please contact your CareTeam for more information. Providers, click here ►
Pick up your specialty medications at CVS/pharmacy It's more convenient than ever. Find out how.
Eric Delson Memorial Scholarship Program
For students diagnosed with Hemophilia or Von Willebrand. Learn more.